AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Frequency and Susceptibility Pattern of Extended Spectrum Beta Lactamase Producing Aerobic Gram Negative Bacteria in Post-Operative Infections

Muhammad Bilal Habib1( )Noreen Sher Akbar2
College of Medical Laboratory Technology National Institute of Health Islamabad Pakistan 44000
DBS & H CEME National University of Sciences and Technology, Islamabad, Pakistan
Show Author Information

Abstract

Extended spectrum β-lactamases occur commonly in the aerobic Gram negative bacteria (AGNB) such as E. coli, Klebsiella spp., Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp., etc. and have the ability to make these organisms resistant to cephalosporins (e.g. ceftazidime, ceftriaxone, cefotaxime etc.), penicillins, and monobactams, i.e. aztreonam. However theses antibiotics become sensitive in the presence of clavulanic acid, an extended spectrum beta-lactamase (ESBL) inhibitor. ESBL enzymes do not influence cephamycins or carbapenems, i.e. meropenem, imipenem, etc. Major problems in surgery is wound infections after operations. High risks of wound infections are due to being immune-comprised on antibiotics, prolonged hospitalization and other factors in many cases. The current research determined various aerobic gram negative bacteria in post-operative wound infections at the College of Medical Laboratory Technology, the National Institute of Health, Islamabad, Pakistan. It also determined the frequency of ESBL in the organisms and established their susceptibility profile during the time period of the research. Infections caused by ESBL producers are a major problem in our post-operative patients. The commonest isolate was E. coli and the commonest ESBL producer was Klebsiella spp. Double disk synergy test is an effective method for screening of such isolates, and the practice of incorporating this test along with the routine sensitivity is recommended.

References

[1]

N. Moremi, V.E. Manda, L. Falgenhauer, et al., Predominance of CTX-M-15 among ESBL producers from environment and fish gut from the shores of Lake Victoria in Mwanza, Tanzania. Front Microbiol., 2016, 7: 1862.

[2]

J.T. Thaden, V.G. Fowler, D.J. Sexton, et al., Increasing incidence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States. Medline, 2016, 37(1): 49-54.

[3]
A. A dedeji, K. Vangala, and G. Saurina, Molecular epidemiology of Klebsiella pneumoniae with extended-spectrum ß-lactamase (ESBLs) in Brooklyn, NY. Proceedings of the 38th Annual Meeting of the Infectious Disease Society of America. New Orleans, USA, Sep. 2000: 7-10.
[4]

M.A. Altayar, A.M. Thokra, and A.M. Mohammad, Extended spectrum β-lactamase-producing Escherchia coli in clinical isolates in Benghazi, Libiya: Phenotypic detection and antimicrobial susceptibility pattern. Medical Journal of Islamic World Academy of Sciences, 2012: 49-56.

[5]

A.R. Anvikar, A. Deshmukh, R.P. Karyakarte, et al., One year prospective study of 3280 surgical wounds. Indian Journal of Medical Microbiology, 1999, 17: 129-132.

[6]

A. Poulou, E. Grivakou, Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test phenotypic detection ESBLs among Enterobacteriaceae producing various β-lactamases. Journal of Clinical Microbiology, 2014, 52(5): 1483-1489.

[7]

B. Blomberg, D.S. Mwakagile, W.K. Urassa, et al., Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health, 2004, 4: 45.

[8]
A.E. Brown. Benson's microbiological applications: Laboratory manual in general microbiology, 9th ed. McGraw Hill, USA. 2000: 259-260.
[9]

P.A. Bradford. Extended spectrum of β-lactamases in the 21-century: Characterization, epidemiology, and detection of this important resistant threat. Clinic. Microbiol. Rev., 2001, 14(4): 933-951.

[10]

K. Bush. New beta lactamases in Gram-negative bacteria: Diversity and impact and selection of antimicrobial therapy. J. Clin. Infect Dis., 2001, 32: 1085-1089.

[11]

U. Chaudhary, R. Aggarwal. Extended spectrum β-lactamases (ESBL) - an emerging threat to clinical therapeutics. Indian J Med Microbial, 2004, 22(2): 75-80.

[12]

M. Cheesbrough. Biochemical tests to identify bacteria. District laboratory practice in tropical countries. Cambridge University Press, UK, 2000: 63-78.

[13]
P.A. Wayne, Performance standards for antimicrobial susceptibility testing; sixteen informational supplement, M. M 1oo-S22, volume 32 number 3. Clinical and Laboratory Standards Institute, 2011.
[14]

R. Colodner, W. Rock, B. Chazan, et al., Risk factor for the development of extended spectrum β-lactamases producing bacteria in non-hospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases, 2004, 23: 163-167.

[15]

D.J. Diekema, H.S. Sader, K. Kugler, et al., Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program. Clin. Infect. Dis., 1999, 29: 595-607.

[16]

A. Ghosh, P.S. Karmakar, J. Pal, et al., Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. J Indian Med Assoc, 2009, 107(1): 21-22, 24-25.

[17]

D. Gould, A. Chamberlain, Gram-negative bacteria. The challenge of preventing cross-infection in hospital wards: a review of the literature. J Clin Nurs, 1994, 3: 339-345.

[18]
J. Harley, L. Prescott, Laboratory exercises in microbiology. Wm. C. Brown Publishers, 1990: 49-53.
[19]

P.S. Hawser, E.R. Badal, K.S. Bouchillon, et al., Antibiotic susceptibility of intra-abdominal infection Isolates from Indian hospitals during 2008. Journal of Medical Microbiology, 2010, 59: 1050-1054.

[20]

A.E. Inkhorn, M.M. Neugauser, D.T. Bearden, et al., Extended spectrum beta lactamases: Frequency, risk factors and outcomes. Pharmacotherapy, 2002, 22: 14-20.

[21]

K. Jabeen, A. Zafar, and R. Hassan, Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc, 2005, 55(10).

[22]

A.A. Kader, K.A. Kumar, Prevalence of extended spectrum β-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J, 2004, 25(5): 570-574.

[23]

C. Kliebe, B.A. Nies, J.F. Meyer, et al., Evolution of plasmid-coded resistance to broadspectrum cephalosporins. Antimicrobial Agent Chemotherapy, 1995, 28: 302-307.

[24]
E.W. Koneman, S.D. Allen, W.M. Jnda, et al. (Eds), Antimicrobial susceptibility testing in color atlas and textbook of diagnostic microbiology, 5th ed. Lippincott, Philadelphia, 1997: 785-856.
[25]

E.F. Lyamuya, S.J. Moyo, E.V. Komba, et al., Prevalence, antimicrobial resistance and associated risk factors for bacteriuria in diabetic women in Dar es Salaam, Tanzania. African Journal of Microbiology Research, 2011, 5: 683-689.

[26]

S. Malik, A. Gupta, K.P. Singh, et al., Isolates from post-operative wound infections at a tertiary care hospital in India. J Infect Dis Antimicrob Agents, 2011, 28: 45-51.

[27]
J.H. Stein, Hospital infection control, internal medicine, 5th ed. 1998.
[28]

P. Mathur, A. Kapil, B. Das, et al., Prevalence of extended spectrum β-lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res, 2002, 115: 153-157.

[29]

B. Mawalla, E.S. Mshana, L.P. Chalya, et al., Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania. BMC Surgery, 2011, 11: 21.

[30]

S.E. Moland, J.A. Black, J. Ourada, et al., Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother, 2002, 46: 3837-3842.

[31]

B.O. Motayo, J.A. Akinbo, I.J. Ogiogwa, et al., Bacteria colonisation and antibiotic susceptibility pattern of wound infections in a hospital in Abeokuta. Frontiers in Science, 2013, 3(1): 43-48.

[32]

H. Mousa, Aerobic, anaerobic and fungal burn wound infections. J Hosp Infect, 1997, 37: 317-323.

[33]

S. Moyo, S. Aboud, M. Kasubi, et al., Bacteria isolated from bloodstream infections at a tertiary hospital in Dar es Salaam, Tanzania - antimicrobial resistance of isolates. S Afr Med J, 2010, 100: 835-838.

[34]

S. Nathisuwan, S. Burgess, and J.S. Lewis. Extended-spectrum ß-lactamases: Epidemiology, detection and treatment. Pharmacotherapy, 2001, 21: 920-928.

[35]

M.A. Omari, I.M. Malonzo, J.J. Bwayo, et al., Pattern of bacterial infection and antimicrobial susceptibility at Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J, 1997, 74(3): 134-137.

[36]
M.F. Owings, J.L. Kozak, Ambulatory and Inpatient Procedures in the United States. Vital Health Statistics 139, 1996, 1998 1-119.
[37]

D.L. Paterson, The epidemiological profile of infections with multidrug resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis, 2006, 43: S43-S48.

[38]

C.C. Sanders, W.E. Jr. Sanders, Beta lactam resistance in gram negative bacteria: Global trends and clinical impact. Clin Infect Dis, 1992, 15: 824- 883.

[39]

R.K. Sanjay, N.M.N. Prasad, and V.S.G. Kumar, A study on isolation and detection of drug resistance gram negative bacilli with special importance to post-operative wound infection. J. Microbiol. Antimicrob., 2010, 2(6): 68-75.

[40]

A. Shriyan, R. Sheetal, and N. Nayak, Aerobic micro-organisms in post-operative wound infections and their antimicrobial susceptibility patterns. Journal of Clinical and Diagnostic Research, 2010, 4: 3392-3396.

[41]

I. Shukia, R. Tiwari, and M. Agraval, Prevalence of extended spectrum â-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J of Med Microbiol, 2004, 22: 87-91.

[42]

S. Singhal, T. Mathur, S. Khan, et al., Evaluation of methods for Amp C beta-lactamase in gram negative clinical isolates fromtertiary care hospitals. Indian J Med Microbiol, 2005, 23: 120-124.

[43]

W.K. Urassa, G. Kagoma, amd N. Lungeland, Antimicrobial susceptibilty of Staphylococcus aureus strain at Muhimbili Medical Centre. Tanzania. East Afr Med J, 1999, 76(12): 693-695.

[44]

G. Zaman, A.K. Karamat, A.S. Abbasi, et al., Prevalence of extended spectrum beta lactamase producing Enterobacteriaceae in nosocomial isolates. Pak Armed Forces Med J, 1999, 49: 91-96.

Nano Biomedicine and Engineering
Pages 138-149
Cite this article:
Bilal Habib M, Sher Akbar N. Frequency and Susceptibility Pattern of Extended Spectrum Beta Lactamase Producing Aerobic Gram Negative Bacteria in Post-Operative Infections. Nano Biomedicine and Engineering, 2019, 11(2): 138-149. https://doi.org/10.5101/nbe.v11i2.p138-149

582

Views

33

Downloads

0

Crossref

0

Scopus

Altmetrics

Received: 18 August 2018
Accepted: 28 March 2019
Published: 16 May 2019
© Muhammad Bilal Habib, Noreen Sher Akbar.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return